{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:57:42Z","timestamp":1792803462927,"version":"4.5.0"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Male pattern hair loss, the clinical manifestation of androgenetic alopecia in men, is a highly prevalent chronic condition associated with significant psychosocial burden, yet current therapies show heterogeneous efficacy and tolerability between individuals. Over the past decade, genome wide association and sequencing studies have identified hundreds of susceptibility loci that converge on androgen signalling, WNT pathways, prostaglandin metabolism, extracellular matrix remodelling, vascular regulation, telomere biology, and cellular metabolism, indicating that male pattern hair loss is mechanistically tractable and strongly genetically determined. In parallel, pharmacogenetic work has linked variants in genes involved in minoxidil bioactivation, 5\u03b1-reductase isoenzyme activity, prostaglandin synthesis, collagen organisation, and vascular tone to differences in treatment response. In this narrative review, we integrate evidence from large genetic studies, targeted pharmacogenetic cohorts, transcriptomic and pathway analyses, and preclinical models to delineate how genetic architecture informs disease mechanisms and modulates the effects of established therapies such as topical and oral minoxidil, finasteride, dutasteride, and prostaglandin-directed approaches. We also discuss emerging targets, including IGF1R, WNT10A, PPARGC1A, and prolactin receptor signalling, and examine how RNA based androgen receptor silencing and stem-cell-derived regenerative strategies exploit these pathways. Together, these data support a shift from empirical prescribing towards genetically informed, mechanism anchored treatment algorithms for male pattern hair loss, in which pharmacogenetic markers, polygenic scores, and multi omic readouts are progressively incorporated into therapeutic decision making and the design of future clinical trials.<\/jats:p>","DOI":"10.3389\/fphar.2026.1765808","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T05:22:31Z","timestamp":1770873751000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies"],"prefix":"10.3389","volume":"17","author":[{"given":"Gustavo","family":"Torres de Souza","sequence":"first","affiliation":[{"name":"Laboratory of Genetics, Fagron Genomics, Research and Development Department","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Williams","sequence":"additional","affiliation":[{"name":"Farjo Hair Institute","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Costa","family":"Vicente Silva","sequence":"additional","affiliation":[{"name":"Fagron BV, Research and Development Department","place":["Rotterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Brand\u00e3o","family":"Chiovatto","sequence":"additional","affiliation":[{"name":"Fagron Brasil","place":["S\u00e3o Paulo, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorana Kuka","family":"Epstein","sequence":"additional","affiliation":[{"name":"Foundation for Hair Restoration","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vila-Vecilla","sequence":"additional","affiliation":[{"name":"Laboratory of Genetics, Fagron Genomics, Research and Development Department","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Russo","sequence":"additional","affiliation":[{"name":"Laboratory of Genetics, Fagron Genomics, Research and Development Department","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/jocd.14983","article-title":"The psychological consequences of androgenetic alopecia: a systematic review","volume":"22","author":"Aukerman","year":"2023","journal-title":"J. Cosmet. Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4103\/2229-5178.137776","article-title":"Androgenetic alopecia, metabolic syndrome, and insulin resistance: is there any association? A case-control study","volume":"5","author":"Bakry","year":"2014","journal-title":"Indian Dermatol Online J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13287-025-04420-4","article-title":"Pathophysiological mechanisms of hair follicle regeneration and potential therapeutic strategies","volume":"16","author":"Bellani","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jaad.2011.05.026","article-title":"A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia","volume":"66","author":"Blume-Peytavi","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13287-025-04372-9","article-title":"Hair growth stimulated by allogenic adipose-derived stem cells supplemented with ATP in a mouse model of dihydrotestosterone-induced androgenetic alopecia","volume":"16","author":"Bran","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.2147\/DDDT.S542000","article-title":"Androgenetic alopecia: an update on pathogenesis and pharmacological treatment","volume":"19","author":"Chen","year":"2025","journal-title":"Drug Des. Devel Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.jid.2016.03.032","article-title":"Differential expression between human dermal papilla cells from balding and non-balding scalps reveals new candidate genes for androgenetic alopecia","volume":"136","author":"Chew","year":"2016","journal-title":"J. Investigative Dermatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.ophtha.2004.02.006","article-title":"Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma","volume":"111","author":"Christiansen","year":"2004","journal-title":"Ophthalmology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9428","DOI":"10.1073\/pnas.0702884104","article-title":"Vitamin D receptor is essential for normal keratinocyte stem cell function","volume":"104","author":"Cianferotti","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1006","DOI":"10.1371\/journal.pone.0001006","article-title":"SIRNA-directed in vivo silencing of androgen receptor inhibits the growth of castration-resistant prostate carcinomas","volume":"2","author":"Compagno","year":"2007","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1677\/joe.1.06685","article-title":"Prolactin delays hair regrowth in mice","volume":"191","author":"Craven","year":"2006","journal-title":"J. Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/cosmetics12050228","article-title":"Genetic insights into Acne, androgenetic alopecia, and alopecia areata: implications for mechanisms and precision dermatology","volume":"12","author":"de Souza","year":"2025","journal-title":"Cosmetics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.abb.2011.10.002","article-title":"The hair cycle and vitamin D receptor","volume":"523","author":"Demay","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"B15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/der2.58","article-title":"Androgenetic alopecia: update on etiology","volume":"2","author":"Dhurat","year":"2021","journal-title":"Dermatol. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00042307-200401000-00010","article-title":"Benign prostatic hyperplasia progression and its impact on treatment","volume":"14","author":"Djavan","year":"2004","journal-title":"Curr. Opin. Urol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1007\/s00266-024-04332-3","article-title":"Effectiveness of exosome treatment in androgenetic alopecia: outcomes of a prospective study","volume":"48","author":"Ersan","year":"2024","journal-title":"Aesthetic Plast. Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"20586","DOI":"10.1021\/acs.jmedchem.5c01739","article-title":"Efficient silencing of androgen receptor gene via UTR-targeting siRNAs for androgenetic alopecia therapy","volume":"68","author":"Feng","year":"2025","journal-title":"J. Med. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"748","DOI":"10.2353\/ajpath.2006.050468","article-title":"Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and\/or paracrine promoter of apoptosis-driven hair follicle regression","volume":"168","author":"Foitzik","year":"2006","journal-title":"Am. J. Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s13555-024-01142-y","article-title":"Utilising SNP association analysis as a prospective approach for personalising androgenetic alopecia treatment","volume":"14","author":"Franc\u00e8s","year":"2024","journal-title":"Dermatol Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/cosmetics12050190","article-title":"26-SNP panel aids guiding androgenetic alopecia therapy and provides insight into mechanisms of action","volume":"12","author":"Gaboardi","year":"2025","journal-title":"Cosmetics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"126ra34","DOI":"10.1126\/scitranslmed.3003122","article-title":"Prostaglandin D 2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia","volume":"4","author":"Garza","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/jid.2011.367","article-title":"Identification of telogen markers underscores that telogen is far from a quiescent hair cycle phase","volume":"132","author":"Geyfman","year":"2012","journal-title":"J. Investigative Dermatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.eururo.2005.06.011","article-title":"The 5\u03b1-Reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population","volume":"48","author":"Giwercman","year":"2005","journal-title":"Eur. Urol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaad.2023.05.048","article-title":"Alopecia \u2013 new building blocks","volume":"89","author":"Goldberg","year":"2023","journal-title":"J. Am. Acad. Dermatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e12686","DOI":"10.1111\/dth.12686","article-title":"Minoxidil in the treatment of androgenetic alopecia","volume":"31","author":"Goren","year":"2018","journal-title":"Dermatol Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/dth.12111","article-title":"Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia","volume":"27","author":"Goren","year":"2014","journal-title":"Dermatol Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/dth.12164","article-title":"Clinical utility and validity of minoxidil response testing in androgenetic alopecia","volume":"28","author":"Goren","year":"2015","journal-title":"Dermatol Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.3390\/ijms21155342","article-title":"Hormonal effects on hair follicles","volume":"21","author":"Grymowicz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/bjd.12443","article-title":"Evidence for a polygenic contribution to androgenetic alopecia","volume":"169","author":"Heilmann","year":"2013","journal-title":"Br. J. Dermatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"14694","DOI":"10.1038\/ncomms14694","article-title":"Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness","volume":"8","author":"Heilmann-Heimbach","year":"2017","journal-title":"Nat. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1515\/medgen-2023-2003","article-title":"Male-pattern hair loss: comprehensive identification of the associated genes as a basis for understanding pathophysiology","volume":"35","author":"Henne","year":"2023","journal-title":"Med. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jaad.2021.11.013","article-title":"The inflammatory component of androgenetic alopecia","volume":"86","author":"Heymann","year":"2022","journal-title":"J. Am. Acad. Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ajhg.2007.11.014","article-title":"Genome-wide scan and fine-mapping linkage study of androgenetic alopecia reveals a locus on chromosome 3q26","volume":"82","author":"Hillmer","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1046\/j.1365-2230.2002.01086.x","article-title":"Male androgenetic alopecia","volume":"27","author":"Hoffmann","year":"2002","journal-title":"Clin. Exp. Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3390\/jcm14061805","article-title":"Characterization and management of adverse events of low-dose oral minoxidil treatment for alopecia: a narrative review","volume":"14","author":"Jimenez-Cauhe","year":"2025","journal-title":"J. Clin. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/cells12060951","article-title":"Human stem cell use in androgenetic alopecia: a systematic review","volume":"12","author":"Krefft-Trzciniecka","year":"2023","journal-title":"Cells"},{"key":"B38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.tem.2010.06.001","article-title":"Prolactin: an emerging force along the cutaneous\u2013endocrine axis","volume":"21","author":"Langan","year":"2010","journal-title":"Trends Endocrinol. and Metabolism"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1365-2133.2012.10856.x","article-title":"Hair follicle stem cell differentiation is inhibited through cross\u2010talk between Wnt\/\u03b2\u2010catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia","volume":"166","author":"Leir\u00f3s","year":"2012","journal-title":"Br. J. Dermatology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1002746","DOI":"10.1371\/journal.pgen.1002746","article-title":"Six novel susceptibility loci for early-onset androgenetic alopecia and their unexpected association with common diseases","volume":"8","author":"Li","year":"2012","journal-title":"PLoS Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.csbj.2024.06.026","article-title":"Application of multi-omics techniques to androgenetic alopecia: current status and perspectives","volume":"23","author":"Li","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"5861","DOI":"10.1038\/ncomms6861","article-title":"Functionally reciprocal mutations of the prolactin signalling pathway define hairy and slick cattle","volume":"5","author":"Littlejohn","year":"2014","journal-title":"Nat. Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"13407","DOI":"10.1074\/jbc.M113.530535","article-title":"Molecular mechanism of substrate specificity for heparan sulfate 2-O-Sulfotransferase","volume":"289","author":"Liu","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1614090","DOI":"10.3389\/fbioe.2025.1614090","article-title":"Subcutaneous injection of genetically engineered exosomes for androgenic alopecia treatment","volume":"13","author":"Liu","year":"","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41572-025-00656-9","article-title":"Androgenetic alopecia","volume":"11","author":"Liu","year":"","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss","volume":"50","author":"Lucky","year":"2004","journal-title":"J. Am. Acad. Dermatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1677\/jme.1.01725","article-title":"Pharmacogenetic analysis of human steroid 5\u03b1 reductase type II: comparison of finasteride and dutasteride","volume":"34","author":"Makridakis","year":"2005","journal-title":"J. Mol. Endocrinol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0140-6736(98)11282-5","article-title":"Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA","volume":"354","author":"Makridakis","year":"1999","journal-title":"Lancet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4103\/ijdvl.IJDVL_262_17","article-title":"Genetic and molecular aspects of androgenetic alopecia","volume":"84","author":"Martinez-Jacobo","year":"2018","journal-title":"Indian J. Dermatol Venereol. Leprol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","article-title":"Minoxidil: mechanisms of action on hair growth","volume":"150","author":"Messenger","year":"2004","journal-title":"Br. J. Dermatology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/bjd.15577","article-title":"Study of gene expression alteration in male androgenetic alopecia: evidence of predominant molecular signalling pathways","volume":"177","author":"Michel","year":"2017","journal-title":"Br. J. Dermatology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1054\/bjoc.2001.1789","article-title":"A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland","volume":"84","author":"Mononen","year":"2001","journal-title":"Br. J. Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1021\/acs.molpharmaceut.2c00510","article-title":"Efficacy of asymmetric siRNA targeting androgen receptors for the treatment of androgenetic alopecia","volume":"20","author":"Moon","year":"2023","journal-title":"Mol. Pharm."},{"key":"B54","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1111\/jocd.14537","article-title":"Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics","volume":"20","author":"Nestor","year":"2021","journal-title":"J. Cosmet. Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1464-410X.2011.10195.x","article-title":"Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)","volume":"108","author":"Nickel","year":"2011","journal-title":"BJU Int."},{"key":"B56","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/exd.12348","article-title":"Does prostaglandin D 2 hold the cure to male pattern baldness?","volume":"23","author":"Nieves","year":"2014","journal-title":"Exp. Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1067\/mjd.2002.124088","article-title":"A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen","year":"2002","journal-title":"J. Am. Acad. Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jaad.2007.04.012","article-title":"A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men","volume":"57","author":"Olsen","year":"2007","journal-title":"J. Am. Acad. Dermatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e1483","DOI":"10.1371\/journal.pone.0001483","article-title":"The vitamin D receptor is a Wnt effector that controls hair follicle differentiation and specifies tumor type in adult epidermis","volume":"3","author":"P\u00e1lmer","year":"2008","journal-title":"PLoS One"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.3390\/medicina59091654","article-title":"Epidemiologic study of gene distribution in Romanian and Brazilian patients with non-cicatricial alopecia","volume":"59","author":"P\u0103un","year":"2023","journal-title":"Med. (B Aires)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/ng.3570","article-title":"Detection and interpretation of shared genetic influences on 42 human traits","volume":"48","author":"Pickrell","year":"2016","journal-title":"Nat. Genet."},{"key":"B62","doi-asserted-by":"publisher","first-page":"472","DOI":"10.5114\/ada.2020.99947","article-title":"Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review","volume":"39","author":"Pietrauszka","year":"2022","journal-title":"Adv. Dermatology Allergology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41467-017-01490-8","article-title":"GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk","volume":"8","author":"Pirastu","year":"2017","journal-title":"Nat. Commun."},{"key":"B64","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jaad.2021.09.040","article-title":"Perifollicular inflammation and follicular spongiosis in androgenetic alopecia","volume":"86","author":"Plante","year":"2022","journal-title":"J. Am. Acad. Dermatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fgene.2018.00057","article-title":"Convergent evolution of slick coat in cattle through truncation mutations in the prolactin receptor","volume":"9","author":"Porto-Neto","year":"2018","journal-title":"Front. Genet."},{"key":"B66","doi-asserted-by":"publisher","first-page":"15560","DOI":"10.1038\/s41598-017-15505-3","article-title":"Extracellular vesicles derived from MSCs activates dermal papilla cell in vitro and promotes hair follicle conversion from telogen to anagen in mice","volume":"7","author":"Rajendran","year":"2017","journal-title":"Sci. Rep."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e13195","DOI":"10.1111\/dth.13195","article-title":"Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil treatment in Brazilian female pattern hair loss patients","volume":"33","author":"Ramos","year":"2020","journal-title":"Dermatol Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/01.ju.0000112918.74410.94","article-title":"Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia","volume":"171","author":"Roehrborn","year":"2004","journal-title":"J. Urology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3390\/cells14211727","article-title":"Therapeutic and clinical potential of adipose-derived stem cell secretome for skin regeneration","volume":"14","author":"Sendera","year":"2025","journal-title":"Cells"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1111\/jocd.16333","article-title":"Platelet\u2010rich fibrin: a review of its role as a new treatment in androgenetic alopecia","volume":"23","author":"Shrestha","year":"2024","journal-title":"J. Cosmet. Dermatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/age.13145","article-title":"Inheritance of the SLICK1 allele of PRLR in cattle","volume":"52","author":"Sosa","year":"2021","journal-title":"Anim. Genet."},{"key":"B72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40257-019-00479-x","article-title":"Female androgenetic alopecia: an update on diagnosis and management","volume":"21","author":"Starace","year":"2020","journal-title":"Am. J. Clin. Dermatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2133.2010.09816.x","article-title":"Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey","volume":"163","author":"Su","year":"2010","journal-title":"Br. J. Dermatology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s10103-019-02783-8","article-title":"A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia","volume":"34","author":"Suchonwanit","year":"2019","journal-title":"Lasers Med. Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1016\/j.jaad.2004.05.002","article-title":"Hypertrichosis of the eyelashes caused by bimatoprost","volume":"51","author":"Tosti","year":"2004","journal-title":"J. Am. Acad. Dermatol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-025-00664-9","article-title":"Alopecia areata","volume":"11","author":"Ungar","year":"2025","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B77","doi-asserted-by":"publisher","first-page":"djw168","DOI":"10.1093\/jnci\/djw168","article-title":"Long-term consequences of finasteride vs placebo in the prostate cancer prevention trial","volume":"108","author":"Unger","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/jid.2015.28","article-title":"Oxidative stress\u2013associated senescence in dermal papilla cells of men with androgenetic alopecia","volume":"135","author":"Upton","year":"2015","journal-title":"J. Investigative Dermatology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.ophtha.2009.10.017","article-title":"Eyelash growth from application of bimatoprost in gel suspension to the base of the eyelashes","volume":"117","author":"Wester","year":"2010","journal-title":"Ophthalmology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1093\/asj\/sjaf092","article-title":"The health benefits of hair transplant surgery","volume":"45","author":"Williams","year":"2025","journal-title":"Aesthet. Surg. J."},{"key":"B81","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/bph.14530","article-title":"Prostaglandin\u2010cytokine crosstalk in chronic inflammation","volume":"176","author":"Yao","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1038\/s41467-018-04807-3","article-title":"Misestimation of heritability and prediction accuracy of male-pattern baldness","volume":"9","author":"Yap","year":"","journal-title":"Nat. Commun."},{"key":"B83","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.1038\/s41467-018-07862-y","article-title":"Dissection of genetic variation and evidence for pleiotropy in male pattern baldness","volume":"9","author":"Yap","year":"","journal-title":"Nat. Commun."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41598-022-05544-w","article-title":"Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia","volume":"12","author":"Yun","year":"2022","journal-title":"Sci. Rep."},{"key":"B85","doi-asserted-by":"publisher","first-page":"18829","DOI":"10.1021\/acs.jmedchem.5c02108","article-title":"Wnt\/\u03b2-Catenin signaling pathway targeting androgenetic alopecia: how far can we Go beyond minoxidil and finasteride?","volume":"68","author":"Zhi","year":"2025","journal-title":"J. Med. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1765808\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:25:37Z","timestamp":1771928737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1765808\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":85,"alternative-id":["10.3389\/fphar.2026.1765808"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1765808","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"article-number":"1765808"}}